These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 25735856)

  • 1. Electrocardiographic Left Ventricular Hypertrophy as a Predictor for Nonsignificant Coronary Artery Disease in Patients With Non-ST-Segment Elevation Myocardial Infarction.
    Misumida N; Kobayashi A; Saeed M; Fox JT; Kanei Y
    Angiology; 2016 Jan; 67(1):27-33. PubMed ID: 25735856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of electrocardiographic and echocardiographic left ventricular hypertrophy to predict adverse events in patients with a first non-ST-elevation acute myocardial infarction.
    Barrabés JA; Figueras J; Cortadellas J; Lidón RM; Ibars S
    Am J Cardiol; 2009 Feb; 103(4):455-60. PubMed ID: 19195501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of presenting electrocardiographic findings on the treatment and outcomes of patients with non-ST-segment elevation myocardial infarction.
    Patel JH; Gupta R; Roe MT; Peng SA; Wiviott SD; Saucedo JF
    Am J Cardiol; 2014 Jan; 113(2):256-61. PubMed ID: 24290492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of left ventricular hypertrophy and diabetes in the presence of transient ischemic dilation of the left ventricle on myocardial perfusion SPECT images.
    Emmett L; Magee M; Freedman SB; Van der Wall H; Bush V; Trieu J; Van Gaal W; Allman KC; Kritharides L
    J Nucl Med; 2005 Oct; 46(10):1596-601. PubMed ID: 16204708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative.
    Patel MR; Chen AY; Peterson ED; Newby LK; Pollack CV; Brindis RG; Gibson CM; Kleiman NS; Saucedo JF; Bhatt DL; Gibler WB; Ohman EM; Harrington RA; Roe MT
    Am Heart J; 2006 Oct; 152(4):641-7. PubMed ID: 16996828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of ventricular fibrillation at reperfusion in patients with acute ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Demidova MM; Carlson J; Erlinge D; Platonov PG
    Am J Cardiol; 2015 Feb; 115(4):417-22. PubMed ID: 25549882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease.
    Agarwal R; Light RP
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):528-36. PubMed ID: 21088286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
    Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
    Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial.
    Planer D; Mehran R; Ohman EM; White HD; Newman JD; Xu K; Stone GW
    Circ Cardiovasc Interv; 2014 Jun; 7(3):285-93. PubMed ID: 24847016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular hypertrophy contributes to Myocardial Ischemia in Non-obstructive Coronary Artery Disease (the MicroCAD study).
    Eskerud I; Gerdts E; Larsen TH; Lønnebakken MT
    Int J Cardiol; 2019 Jul; 286():1-6. PubMed ID: 30952529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic left ventricular hypertrophy is not associated with increased in-hospital adverse events in patients with first Non-ST segment elevation myocardial infarction: A single center study.
    Bakhtiari F; Davarmoin G; Ghaffari S; Aslanabadi N; Separham A
    Caspian J Intern Med; 2019; 10(3):289-294. PubMed ID: 31558990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term outcomes of patients with electrocardiographic left ventricular hypertrophy after fibrinolysis for acute myocardial infarction.
    Georgescu A; Fu Y; Yau C; Hassan Q; Luchansky J; Armstrong PW; Wagner G; Van de Werf F; Goodman SG;
    Am J Cardiol; 2005 Oct; 96(8):1050-2. PubMed ID: 16214436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiographic left ventricular hypertrophy in patients with suspected acute cardiac ischemia--its influence on diagnosis, triage, and short-term prognosis: a multicenter study.
    Larsen GC; Griffith JL; Beshansky JR; D'Agostino RB; Selker HP
    J Gen Intern Med; 1994 Dec; 9(12):666-73. PubMed ID: 7876948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-to-lymphocyte ratio as an independent predictor of left main and/or three-vessel disease in patients with non-ST-segment elevation myocardial infarction.
    Misumida N; Kobayashi A; Saeed M; Fox JT; Kanei Y
    Cardiovasc Revasc Med; 2015 Sep; 16(6):331-5. PubMed ID: 26051172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Coronary Artery Plaque Area is Associated with Myocardial Hypoperfusion in Women with Non-ST Elevation Myocardial Infarction.
    Eskerud I; Gerdts E; Nordrehaug JE; Lønnebakken MT
    J Womens Health (Larchmt); 2015 May; 24(5):367-73. PubMed ID: 25692527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial).
    Larsen AI; Nilsen DW; Yu J; Mehran R; Nikolsky E; Lansky AJ; Caixeta A; Parise H; Fahy M; Cristea E; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Stone GW
    Am J Cardiol; 2013 Mar; 111(5):643-8. PubMed ID: 23261001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women.
    Westerhout CM; Lauer MS; James S; Fu Y; Wallentin L; Armstrong PW;
    Eur Heart J; 2007 Sep; 28(17):2064-9. PubMed ID: 17600040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.